In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols Babesia test for samples received on April 20, 2020 at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Be watching for details on an upcoming webinar that will provide you with an overview of implementing this testing.
Check out the Communication page for the complete details by clicking the link: Communications
The new online Learning Center with new content can still be found under the “Training” folder on ...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...
This is the first update to the original CTS communication distributed on July 6th. As previously co...
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...